[email protected]
CDI - Contrive Datum Insights
Healthcare Services

Home Infusion Therapy MarketSize, Share & Industry Analysis, 2026-2034By Therapy TypeBy ProductBy Service TypeBy Route of AdministrationBy IndicationBy Provider TypeBy Patient Age GroupBy Payer TypeBy Care SettingBy Duration of Therapy

Full title & scope — all 10 axes with their segments

Home Infusion Therapy Market Size, Share & Industry Analysis, By Therapy Type (Anti-Infective Therapy, Parenteral Nutrition, Enteral Nutrition, Immunoglobulin Therapy, Chemotherapy, Pain Management, Hydration Therapy, Inotropic and Cardiac Therapy, Specialty Biologics and Rare Disease Therapies), By Product (Infusion Pumps, IV Sets and Administration Sets, IV Catheters and Access Devices, IV Bags and Containers, Needleless Connectors and Accessories), By Service Type (Pharmacy Compounding and Dispensing, Skilled Nursing and Clinical Services, Equipment Rental and Supply, Patient Training and Care Coordination, Remote Patient Monitoring and Telepharmacy), By Route of Administration (Intravenous, Subcutaneous, Enteral, Epidural and Intrathecal, Intramuscular), By Indication (Infectious Diseases, Cancer, Primary and Secondary Immunodeficiency, Gastrointestinal Disorders and Short Bowel Syndrome, Neurological and Autoimmune Disorders, Hemophilia and Bleeding Disorders, Cardiovascular Disorders, Diabetes, Chronic Pain), By Provider Type (Independent Home Infusion Pharmacies, Hospital-Based Infusion Providers, Payer-Owned Infusion Providers, Specialty Pharmacy-Affiliated Providers, Home Health Agency-Based Providers), By Patient Age Group (Pediatric, Adult, Geriatric), By Payer Type (Medicare, Medicaid and Government Programs, Commercial Insurance, Out-of-Pocket and Self-Pay), By Care Setting (Patient Home, Ambulatory Infusion Suites, Assisted Living Facilities, Skilled Nursing Facilities), By Duration of Therapy (Short-Term (Acute) Therapy, Long-Term (Chronic) Therapy, Intermittent and Episodic Therapy), and Regional Forecast, 2026-2034

Last Updated: Nov 18, 2026Format: PDFReport ID: CDI-248901
Segmentation

Segment definitions and share of revenue by product, animal, end user and region.

Segmented by
Therapy Type
Product
Service Type
Route Of Administration
Indication
Provider Type
Patient Age Group
Payer Type
Care Setting
Duration Of Therapy
Structure

Segmentation Analysis

10 axes

By Therapy Type

9
  • 01Anti-Infective Therapy
  • 02Parenteral Nutrition
  • 03Enteral Nutrition
  • 04Immunoglobulin Therapy
  • 05Chemotherapy
  • 06Pain Management
  • 07Hydration Therapy
  • 08Inotropic and Cardiac Therapy
  • 09Specialty Biologics and Rare Disease Therapies

By Product

5
  • 01Infusion Pumps
  • 02IV Sets and Administration Sets
  • 03IV Catheters and Access Devices
  • 04IV Bags and Containers
  • 05Needleless Connectors and Accessories

By Service Type

5
  • 01Pharmacy Compounding and Dispensing
  • 02Skilled Nursing and Clinical Services
  • 03Equipment Rental and Supply
  • 04Patient Training and Care Coordination
  • 05Remote Patient Monitoring and Telepharmacy

By Route of Administration

5
  • 01Intravenous
  • 02Subcutaneous
  • 03Enteral
  • 04Epidural and Intrathecal
  • 05Intramuscular

By Indication

9
  • 01Infectious Diseases
  • 02Cancer
  • 03Primary and Secondary Immunodeficiency
  • 04Gastrointestinal Disorders and Short Bowel Syndrome
  • 05Neurological and Autoimmune Disorders
  • 06Hemophilia and Bleeding Disorders
  • 07Cardiovascular Disorders
  • 08Diabetes
  • 09Chronic Pain

By Provider Type

5
  • 01Independent Home Infusion Pharmacies
  • 02Hospital-Based Infusion Providers
  • 03Payer-Owned Infusion Providers
  • 04Specialty Pharmacy-Affiliated Providers
  • 05Home Health Agency-Based Providers

By Patient Age Group

3
  • 01Pediatric
  • 02Adult
  • 03Geriatric

By Payer Type

4
  • 01Medicare
  • 02Medicaid and Government Programs
  • 03Commercial Insurance
  • 04Out-of-Pocket and Self-Pay

By Care Setting

4
  • 01Patient Home
  • 02Ambulatory Infusion Suites
  • 03Assisted Living Facilities
  • 04Skilled Nursing Facilities

By Duration of Therapy

3
  • 01Short-Term (Acute) Therapy
  • 02Long-Term (Chronic) Therapy
  • 03Intermittent and Episodic Therapy

Segment categories shown for scope reference. See the Summary tab for revenue share by Therapy Type. Full segment-by-segment detail across every axis is available in the sample and full report.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Home Infusion Therapy Market projected to reach?

USD 82.96 USD Billion by 2034, CAGR 8%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which segment leads the market?

Anti-Infective Therapy is the largest line by therapy type, at 26.99% of revenue in 2025.

05Who are the key companies profiled?

Option Care Health, Inc., Optum Infusion Pharmacy (UnitedHealth Group Incorporated), Coram (CVS Health Corporation), BrightSpring Health Services, Inc., Amerita, Inc., KabaFusion, Baxter International Inc., B. Braun Melsungen AG, BD (Becton, Dickinson and Company), ICU Medical, Inc., Fresenius Kabi AG, Soleo Health, Triple Crown Infusion Services, Vivo Infusion, Premier Infusion Care, Wellsky Corporation (CareCentrix), Avant Healthcare Professionals, ARJ Infusion Services, Eversana Life Science Services LLC, Smiths Medical (ICU Medical), Moog Medical Devices Group, Terumo Corporation, Nipro Corporation, Zyno Medical, InfuSystem Holdings, Inc., Sanofi (Home infusion support), Takeda Pharmaceutical Company Limited, CSL Behring (CSL Limited), Fresenius Kabi Home Care, Medline Industries, LP, Apria Healthcare Group, Lincare Holdings Inc., Linde Healthcare Homecare, Vitalaire (Air Liquide Santé), Orkla Care. Full profiles are part of the paid report.

06Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.